Stephanie Allen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stephanie Allen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dae Yong Park
Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA
1 shared publication - Evangelia Vemmou
Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT 06520, USA
1 shared publication - Ilhan Gokhan
Department of Biomedical Engineering (I.G., M.M., X.L., M.Z., J.M.S., F.G.A., S.G.C.), Yale University, New Haven, CT
1 shared publication - Jennifer M. Kwan
Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA
1 shared publication - Jiun-Ruey Hu
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
1 shared publication - Marah Maayah
Department of Psychiatry and Women’s Health Research at Yale Yale University School of Medicine New Haven CT
1 shared publication
Latest Publications
- Open Access
- 26 February 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 503
Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing
Cardiac troponin (Tn) plays a central role in the evaluation of patients with angina presenting with acute coronary syndrome. The advent of high-sensitivity assays has improved the analytic sensitivity and precision of serum Tn measurement, but this advancement has come at the cost of poorer specificity. The role of clinical judgment is of heightened importance because, more so than ever, the interpretation of serum Tn elevation hinges on the careful integration of findings from electrocardiographic, echocardiographic, physical exam, interview, and other imaging and laboratory data to formulate a weighted differential diagnosis. A thorough understanding of the epidemiology, mechanisms, and prognostic implications of Tn elevations in each cardiac and non-cardiac etiology allows the clinician to better distinguish between presentations of myocardial ischemia and myocardial injury—an important discernment to make, as the treatment of acute coronary syndrome is vastly different from the workup and management of myocardial injury and should be directed at the underlying cause.
- 26 February 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 503
Open AccessClinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing
Cardiac troponin (Tn) plays a central role in the evaluation of patients with angina presenting with acute coronary syndrome. The advent of high-sensitivity assays has improved the analytic sensitivity and precision of serum Tn measurement, but this advancement has come at the cost of poorer specificity. The role of clinical judgment is of heightened importance because, more so than ever, the interpretation of serum Tn elevation hinges on the careful integration of findings from electrocardiographic, echocardiographic, physical exam, interview, and other imaging and laboratory data to formulate a weighted differential diagnosis. A thorough understanding of the epidemiology, mechanisms, and prognostic implications of Tn elevations in each cardiac and non-cardiac etiology allows the clinician to better distinguish between presentations of myocardial ischemia and myocardial injury—an important discernment to make, as the treatment of acute coronary syndrome is vastly different from the workup and management of myocardial injury and should be directed at the underlying cause.